Takeda Gmbh

Ewald Benediktus

Thomas Maier

Beate Schmidt

Dieter Flockerzi

Alexander Sudau

Ulrich Kautz

Degenhard Marx

Martin Viertelhaus

Christian Hesslinger

Rolf-Peter Hummel

Stefan Fischer

Andreas Pahl

Josef Stadlwieser

Torsten Dunkern

Heiko Bernsmann

Ragna Hussong

Olaf Nimz

Matthias Mueller

Manuela Hessmann

Alexander Mann

Harald Ohmer

Hans Christof Holst

Tobias Kanacher

Matthias MÜLLER

The compounds of Formula (I), wherein R1, R2, R21, R22, R23, R24, Y and R3 have the meanings as given in the description, the salts thereof, the stereoisomers of the compounds and the salts thereof are effective inhibitors of the type 5 phosphodiesterase and are useful for treating or preventing idiopathic pulmonary lung fibrosis.

Methylpyrrolopyrimidinecarboxamides

The compounds of Formula (I), wherein R1, R2, R21, R22, R23, R24, Y and R3 have the meanings as given in the description, the salts thereof, the stereoisomers of the compounds and the salts thereof are effective inhibitors of the type 5 phosphodiesterase.

The compounds of Formula (I), wherein R1, R21, R22, R23, R24, Y and R3 have the meanings as given in the description, the salts thereof, the stereoisomers of the compounds and the salts thereof are effective inhibitors of the type 5 phosphodiesterase.

Methylpyrrolopyridinecarboxamides

Growing community of inventors

Biberach, Germany

Ewald Benediktus